Hasil Pencarian (1)
biotech | CAS: 2019171-69-6
Pegcetacoplan is a complement inhibitor indicated in the treatment of paroxysmal nocturnal hemoglobinuria (PNH).[A235000,L34095] Prior to its FDA approval, patients with PNH were typically treated with the C5 inhibiting monoclonal antibody [eculizumab].[A2350…
Kategori:
Amino Acids, Peptides, and ProteinsAntineoplastic and Immunomodulating AgentsComplement Inactivating Agents
+6
Target Protein:
Complement C3
Waktu ParuhThe median half lif…
Vol. DistribusiThe volume of distr…
KlirensThe mean clearance …
Genetik
-